A citation-based method for searching scientific literature

Joan L Kramer, Isela A Velazquez, Bingshu E Chen, Philip S Rosenberg, Jeffery P Struewing, Mark H Greene. J Clin Oncol 2005
Times Cited: 96



Marcia S Brose, Timothy R Rebbeck, Kathleen A Calzone, Jill E Stopfer, Katherine L Nathanson, Barbara L Weber. J Natl Cancer Inst 2002
Times Cited: 458




List of shared articles



Times cited


Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
487


Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery.
Mohamed Salhab, Selina Bismohun, Kefah Mokbel. BMC Womens Health 2010
41

Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
Julie D Lamb, Rochelle L Garcia, Barbara A Goff, Pamela J Paley, Elizabeth M Swisher. Am J Obstet Gynecol 2006
65



BRCA1-induced ovarian oncogenesis.
Louis Dubeau. Adv Exp Med Biol 2008
1


Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome.
Dimitrios H Roukos, Evangelos Briasoulis. Nat Clin Pract Oncol 2007
90

Clinical management of hereditary breast cancer syndromes.
Amy S Clark, Susan M Domchek. J Mammary Gland Biol Neoplasia 2011
30

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Timothy R Rebbeck, Susan M Domchek. Breast Cancer Res 2008
13

Bias Correction Methods Explain Much of the Variation Seen in Breast Cancer Risks of BRCA1/2 Mutation Carriers.
Janet R Vos, Li Hsu, Richard M Brohet, Marian J E Mourits, Jakob de Vries, Kathleen E Malone, Jan C Oosterwijk, Geertruida H de Bock. J Clin Oncol 2015
16